This company, formerly known as Glaxo Smithkline plc, is a world leading research-based pharmaceutical company which manufactures various pharmaceutical products. Headquartered in Brentford, United Kingdom, the company has its operations based in the United States. The name of the company evolved after Glaxo Wellcome and SmithKline Beecham merged in January 2000-the date it was founded. The company produces medicines that treat six major disease areas - asthma, virus control, infections, mental health, diabetes, and digestive conditions. In addition, it is a leader in the important area of vaccines and is developing new treatments for cancer. The company's products and services are grouped into prescription medicines, vaccines, and consumer healthcare, which include brands such as Panadol, Aquafresh, Lucozade, Ribena, Horlicks, Nicorette/Niquitin, Gaviscon, and Macleans. The company is one of the largest collaborators in the pharmaceutical industry in the world. It works with more than 50 academic institutions and other pharmaceutical and biotechnology companies. It provides a wide range of pharmaceutical products to address many of the world's major healthcare needs. The company also has a leadership in four major therapeutic areas: anti-infectives, central nervous systems, respiratory, and gastrointestinal/metabolic.The company is committed to fighting filariasis through its membership of the Global Alliance to Eliminate Lymphatic Filariasis. It is active in 70 countries in Europe, North and South America, Caricam, Andina, Asia and Australasia, Southeast Asia, Africa, and the Middle East.
La versione in sola lettura del questionario inviato a questa azienda è disponibile pubblicamente: vedi questionario.